25 XP   0   0   10

Wuhan Thalys Med Tech Co Ltd
Buy, Hold or Sell?

Let's analyse Thalys together

PenkeI guess you are interested in Wuhan Thalys Med Tech Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wuhan Thalys Med Tech Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Wuhan Thalys Med Tech Co Ltd

I send you an email if I find something interesting about Wuhan Thalys Med Tech Co Ltd.

Quick analysis of Thalys (30 sec.)










What can you expect buying and holding a share of Thalys? (30 sec.)

How much money do you get?

How much money do you get?
¥0.02
When do you have the money?
1 year
How often do you get paid?
97.1%

What is your share worth?

Current worth
¥6.54
Expected worth in 1 year
¥5.75
How sure are you?
79.4%

+ What do you gain per year?

Total Gains per Share
¥-0.63
Return On Investment
-8.5%

For what price can you sell your share?

Current Price per Share
¥7.43
Expected price per share
¥5.2 - ¥11.59
How sure are you?
50%

1. Valuation of Thalys (5 min.)




Live pricePrice per Share (EOD)

¥7.43

Intrinsic Value Per Share

¥-3.51 - ¥-4.13

Total Value Per Share

¥3.03 - ¥2.42

2. Growth of Thalys (5 min.)




Is Thalys growing?

Current yearPrevious yearGrowGrow %
How rich?$182.2m$223.1m-$27.5m-14.1%

How much money is Thalys making?

Current yearPrevious yearGrowGrow %
Making money-$4.8m-$6.5m$1.7m35.6%
Net Profit Margin-7.5%-8.8%--

How much money comes from the company's main activities?

3. Financial Health of Thalys (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#62 / 144

Most Revenue
#58 / 144

Most Profit
#95 / 144

What can you expect buying and holding a share of Thalys? (5 min.)

Welcome investor! Thalys's management wants to use your money to grow the business. In return you get a share of Thalys.

What can you expect buying and holding a share of Thalys?

First you should know what it really means to hold a share of Thalys. And how you can make/lose money.

Speculation

The Price per Share of Thalys is ¥7.43. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Thalys.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Thalys, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥6.54. Based on the TTM, the Book Value Change Per Share is ¥-0.20 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.32 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Thalys.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.02-0.3%-0.03-0.4%-0.01-0.1%0.000.0%
Usd Book Value Change Per Share0.010.1%-0.03-0.4%-0.04-0.6%-0.01-0.2%0.030.4%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.010.1%-0.02-0.3%-0.03-0.5%0.000.0%0.030.5%
Usd Price Per Share1.12-1.38-1.54-1.86-3.19-
Price to Earnings Ratio128.67-11.74--37.50--21.17-26.23-
Price-to-Total Gains Ratio129.24-82.37-30.37-73.86-144.18-
Price to Book Ratio1.23-1.43-1.41-1.66-4.06-
Price-to-Total Gains Ratio129.24-82.37-30.37-73.86-144.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.028312
Number of shares972
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.020.00
Gains per Quarter (972 shares)-21.32-2.83
Gains per Year (972 shares)-85.28-11.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
121-106-9535-46-21
242-212-18069-92-32
363-318-265104-138-43
484-425-350139-184-54
5104-531-435173-230-65
6125-637-520208-276-76
7146-743-605242-322-87
8167-849-690277-368-98
9188-955-775312-414-109
10209-1062-860346-460-120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%3.09.00.025.0%10.010.00.050.0%24.010.00.070.6%24.010.00.070.6%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%12.08.00.060.0%23.09.02.067.6%23.09.02.067.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%33.00.01.097.1%33.00.01.097.1%
Total Gains per Share3.01.00.075.0%7.05.00.058.3%14.06.00.070.0%27.06.01.079.4%27.06.01.079.4%

Fundamentals of Thalys

About Wuhan Thalys Med Tech Co Ltd

Thalys Medical Technology Group Corporation provides intensive operation services of medical inspection in China. The company was formerly known as Thalys Medical Technology Inc. and changed its name to Thalys Medical Technology Group Inc. in September 2020. Thalys Medical Technology Group Inc. was founded in 2004 and is headquartered in Wuhan, China.

Fundamental data was last updated by Penke on 2024-05-13 12:11:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Wuhan Thalys Med Tech Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Thalys earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.7% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.7%. The company is not making a profit/loss.
  • The TTM is -7.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-7.5%+8.1%
TTM-7.5%YOY-8.8%+1.3%
TTM-7.5%5Y-2.2%-5.3%
5Y-2.2%10Y2.5%-4.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%-7.8%+8.5%
TTM-7.5%-7.5%+0.0%
YOY-8.8%-2.4%-6.4%
5Y-2.2%-2.8%+0.6%
10Y2.5%-3.1%+5.6%
1.1.2. Return on Assets

Shows how efficient Thalys is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • 0.1% Return on Assets means that Thalys generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -1.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-1.1%+1.2%
TTM-1.1%YOY-1.2%+0.1%
TTM-1.1%5Y-0.3%-0.8%
5Y-0.3%10Y0.5%-0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1%-1.6%+1.7%
TTM-1.1%-1.1%+0.0%
YOY-1.2%-0.9%-0.3%
5Y-0.3%-0.3%+0.0%
10Y0.5%-0.4%+0.9%
1.1.3. Return on Equity

Shows how efficient Thalys is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • 0.3% Return on Equity means Thalys generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -2.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.3%TTM-2.9%+3.2%
TTM-2.9%YOY-3.4%+0.4%
TTM-2.9%5Y-0.9%-2.0%
5Y-0.9%10Y0.5%-1.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-0.9%+1.2%
TTM-2.9%0.1%-3.0%
YOY-3.4%-0.3%-3.1%
5Y-0.9%-1.3%+0.4%
10Y0.5%-1.3%+1.8%

1.2. Operating Efficiency of Wuhan Thalys Med Tech Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Thalys is operating .

  • Measures how much profit Thalys makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.8%-1.8%
TTM1.8%YOY1.4%+0.4%
TTM1.8%5Y5.0%-3.1%
5Y5.0%10Y3.3%+1.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.7%+15.7%
TTM1.8%0.2%+1.6%
YOY1.4%4.1%-2.7%
5Y5.0%0.9%+4.1%
10Y3.3%-1.2%+4.5%
1.2.2. Operating Ratio

Measures how efficient Thalys is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.71 means that the operating costs are ¥1.71 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.705. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.788. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.705TTM1.788-0.083
TTM1.788YOY1.799-0.010
TTM1.7885Y1.718+0.070
5Y1.71810Y1.270+0.448
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7051.335+0.370
TTM1.7881.343+0.445
YOY1.7991.267+0.532
5Y1.7181.259+0.459
10Y1.2701.207+0.063

1.3. Liquidity of Wuhan Thalys Med Tech Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Thalys is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.75 means the company has ¥1.75 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.753. The company is able to pay all its short-term debts. +1
  • The TTM is 1.722. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.753TTM1.722+0.031
TTM1.722YOY1.667+0.055
TTM1.7225Y1.859-0.136
5Y1.85910Y1.152+0.707
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7532.169-0.416
TTM1.7222.423-0.701
YOY1.6672.599-0.932
5Y1.8593.012-1.153
10Y1.1522.995-1.843
1.3.2. Quick Ratio

Measures if Thalys is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.15 means the company can pay off ¥1.15 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.153. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.134. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.153TTM1.134+0.019
TTM1.134YOY1.150-0.016
TTM1.1345Y1.152-0.018
5Y1.15210Y1.195-0.043
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1531.215-0.062
TTM1.1341.285-0.151
YOY1.1501.785-0.635
5Y1.1521.980-0.828
10Y1.1952.196-1.001

1.4. Solvency of Wuhan Thalys Med Tech Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Thalys assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Thalys to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.60 means that Thalys assets are financed with 60.2% credit (debt) and the remaining percentage (100% - 60.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 0.602. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.600. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.602TTM0.600+0.002
TTM0.600YOY0.601-0.001
TTM0.6005Y0.551+0.049
5Y0.55110Y0.452+0.099
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6020.432+0.170
TTM0.6000.403+0.197
YOY0.6010.381+0.220
5Y0.5510.438+0.113
10Y0.4520.441+0.011
1.4.2. Debt to Equity Ratio

Measures if Thalys is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Thalys to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 165.6% means that company has ¥1.66 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The MRQ is 1.656. The company is just able to pay all its debts with equity.
  • The TTM is 1.633. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.656TTM1.633+0.023
TTM1.633YOY1.649-0.016
TTM1.6335Y1.385+0.248
5Y1.38510Y1.014+0.371
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6560.612+1.044
TTM1.6330.559+1.074
YOY1.6490.529+1.120
5Y1.3850.635+0.750
10Y1.0140.724+0.290

2. Market Valuation of Wuhan Thalys Med Tech Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Thalys generates.

  • Above 15 is considered overpriced but always compare Thalys to the Diagnostics & Research industry mean.
  • A PE ratio of 128.67 means the investor is paying ¥128.67 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is 118.462. Based on the earnings, the company is expensive. -2
  • The MRQ is 128.666. Based on the earnings, the company is expensive. -2
  • The TTM is 11.737. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD118.462MRQ128.666-10.204
MRQ128.666TTM11.737+116.929
TTM11.737YOY-37.502+49.239
TTM11.7375Y-21.171+32.908
5Y-21.17110Y26.229-47.400
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD118.462-0.357+118.819
MRQ128.666-0.616+129.282
TTM11.737-0.179+11.916
YOY-37.502-0.145-37.357
5Y-21.1711.547-22.718
10Y26.2295.694+20.535
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is -12.100. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -13.142. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 17.585. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-12.100MRQ-13.142+1.042
MRQ-13.142TTM17.585-30.727
TTM17.585YOY12.420+5.164
TTM17.5855Y11.857+5.728
5Y11.85710Y7.681+4.176
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-12.100-0.777-11.323
MRQ-13.142-1.176-11.966
TTM17.585-1.088+18.673
YOY12.420-2.547+14.967
5Y11.857-1.352+13.209
10Y7.681-2.503+10.184
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Thalys is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.23 means the investor is paying ¥1.23 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Wuhan Thalys Med Tech Co Ltd:

  • The EOD is 1.136. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.234. Based on the equity, the company is underpriced. +1
  • The TTM is 1.432. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.136MRQ1.234-0.098
MRQ1.234TTM1.432-0.198
TTM1.432YOY1.413+0.019
TTM1.4325Y1.661-0.229
5Y1.66110Y4.059-2.398
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.1362.033-0.897
MRQ1.2342.211-0.977
TTM1.4322.157-0.725
YOY1.4132.726-1.313
5Y1.6613.460-1.799
10Y4.0594.029+0.030
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Wuhan Thalys Med Tech Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.036-0.197+641%-0.319+975%-0.085+334%0.192-81%
Book Value Per Share--6.5426.986-6%7.908-17%8.063-19%6.823-4%
Current Ratio--1.7531.722+2%1.667+5%1.859-6%1.152+52%
Debt To Asset Ratio--0.6020.600+0%0.601+0%0.551+9%0.452+33%
Debt To Equity Ratio--1.6561.633+1%1.649+0%1.385+20%1.014+63%
Dividend Per Share--0.0260.039-33%0.070-63%0.064-60%0.057-55%
Eps--0.016-0.174+1209%-0.234+1591%-0.052+435%0.014+16%
Free Cash Flow Per Share---0.1540.024-749%0.162-195%-0.044-71%-0.054-65%
Free Cash Flow To Equity Per Share---0.154-0.094-38%-0.525+242%-0.094-39%-0.092-40%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.971+3%
Intrinsic Value_10Y_max---4.125--------
Intrinsic Value_10Y_min---3.508--------
Intrinsic Value_1Y_max---0.258--------
Intrinsic Value_1Y_min---0.253--------
Intrinsic Value_3Y_max---0.893--------
Intrinsic Value_3Y_min---0.850--------
Intrinsic Value_5Y_max---1.671--------
Intrinsic Value_5Y_min---1.541--------
Market Cap1495829949.440-9%1624679394.1502019747929.910-20%2274699564.553-29%2744518525.806-41%4655689734.543-65%
Net Profit Margin--0.007-0.075+1251%-0.088+1453%-0.022+440%0.025-74%
Operating Margin---0.018-100%0.014-100%0.050-100%0.033-100%
Operating Ratio--1.7051.788-5%1.799-5%1.718-1%1.270+34%
Pb Ratio1.136-9%1.2341.432-14%1.413-13%1.661-26%4.059-70%
Pe Ratio118.462-9%128.66611.737+996%-37.502+129%-21.171+116%26.229+391%
Price Per Share7.430-9%8.0709.985-19%11.153-28%13.456-40%23.021-65%
Price To Free Cash Flow Ratio-12.100+8%-13.14217.585-175%12.420-206%11.857-211%7.681-271%
Price To Total Gains Ratio118.990-9%129.23982.366+57%30.373+326%73.863+75%144.176-10%
Quick Ratio--1.1531.134+2%1.150+0%1.152+0%1.195-4%
Return On Assets--0.001-0.011+1209%-0.012+1357%-0.003+371%0.005-82%
Return On Equity--0.003-0.029+1216%-0.034+1376%-0.009+437%0.005-48%
Total Gains Per Share--0.062-0.158+354%-0.249+499%-0.021+134%0.250-75%
Usd Book Value--182269359.231195603749.479-7%223175046.080-18%227608345.648-20%191835787.372-5%
Usd Book Value Change Per Share--0.005-0.027+641%-0.044+975%-0.012+334%0.027-81%
Usd Book Value Per Share--0.9050.967-6%1.094-17%1.116-19%0.944-4%
Usd Dividend Per Share--0.0040.005-33%0.010-63%0.009-60%0.008-55%
Usd Eps--0.002-0.024+1209%-0.032+1591%-0.007+435%0.002+16%
Usd Free Cash Flow---4277266.180682557.199-727%4562452.373-194%-1252068.091-71%-1030652.534-76%
Usd Free Cash Flow Per Share---0.0210.003-749%0.022-195%-0.006-71%-0.007-65%
Usd Free Cash Flow To Equity Per Share---0.021-0.013-38%-0.073+242%-0.013-39%-0.013-40%
Usd Market Cap207022865.002-9%224855628.150279533113.500-20%314818419.734-29%379841363.971-41%644347459.261-65%
Usd Price Per Share1.028-9%1.1171.382-19%1.544-28%1.862-40%3.186-65%
Usd Profit--436898.468-4861540.016+1213%-6591664.070+1609%-1474345.983+437%276444.536+58%
Usd Revenue--67140873.98770832666.855-5%75214060.689-11%76090545.386-12%56886130.614+18%
Usd Total Gains Per Share--0.009-0.022+354%-0.034+499%-0.003+134%0.035-75%
 EOD+3 -5MRQTTM+17 -18YOY+19 -165Y+16 -1910Y+9 -27

3.2. Fundamental Score

Let's check the fundamental score of Wuhan Thalys Med Tech Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15118.462
Price to Book Ratio (EOD)Between0-11.136
Net Profit Margin (MRQ)Greater than00.007
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.153
Current Ratio (MRQ)Greater than11.753
Debt to Asset Ratio (MRQ)Less than10.602
Debt to Equity Ratio (MRQ)Less than11.656
Return on Equity (MRQ)Greater than0.150.003
Return on Assets (MRQ)Greater than0.050.001
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Wuhan Thalys Med Tech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.079
Ma 20Greater thanMa 507.146
Ma 50Greater thanMa 1007.672
Ma 100Greater thanMa 2008.594
OpenGreater thanClose7.590
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets3,306,186
Total Liabilities1,989,211
Total Stockholder Equity1,201,140
 As reported
Total Liabilities 1,989,211
Total Stockholder Equity+ 1,201,140
Total Assets = 3,306,186

Assets

Total Assets3,306,186
Total Current Assets2,365,757
Long-term Assets940,429
Total Current Assets
Cash And Cash Equivalents 175,356
Net Receivables 1,555,375
Inventory 376,400
Other Current Assets 4,911
Total Current Assets  (as reported)2,365,757
Total Current Assets  (calculated)2,112,043
+/- 253,714
Long-term Assets
Property Plant Equipment 199,943
Goodwill 115,804
Intangible Assets 34,564
Long-term Assets Other 52,887
Long-term Assets  (as reported)940,429
Long-term Assets  (calculated)403,198
+/- 537,232

Liabilities & Shareholders' Equity

Total Current Liabilities1,349,228
Long-term Liabilities639,983
Total Stockholder Equity1,201,140
Total Current Liabilities
Short Long Term Debt 465,989
Accounts payable 732,592
Other Current Liabilities 14,531
Total Current Liabilities  (as reported)1,349,228
Total Current Liabilities  (calculated)1,213,113
+/- 136,115
Long-term Liabilities
Long term Debt 573,526
Capital Lease Obligations Min Short Term Debt31,744
Long-term Liabilities Other 20,846
Long-term Liabilities  (as reported)639,983
Long-term Liabilities  (calculated)626,115
+/- 13,868
Total Stockholder Equity
Retained Earnings 257,408
Total Stockholder Equity (as reported)1,201,140
Total Stockholder Equity (calculated)257,408
+/- 943,732
Other
Capital Stock201,323
Common Stock Shares Outstanding 201,323
Net Debt 864,158
Net Invested Capital 2,240,654
Net Working Capital 1,016,529
Property Plant and Equipment Gross 199,943



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
314,157
388,797
437,791
537,573
663,267
0
727,648
774,162
1,092,481
1,097,198
1,277,841
1,452,629
1,569,391
1,656,942
2,434,919
2,421,909
0
2,797,260
3,027,714
3,026,014
3,007,056
3,208,849
3,059,482
3,683,049
3,906,340
4,028,170
3,961,148
4,127,347
4,293,574
4,489,442
4,270,069
4,180,329
3,947,451
3,738,068
3,725,346
3,752,691
3,341,784
3,306,186
3,306,1863,341,7843,752,6913,725,3463,738,0683,947,4514,180,3294,270,0694,489,4424,293,5744,127,3473,961,1484,028,1703,906,3403,683,0493,059,4823,208,8493,007,0563,026,0143,027,7142,797,26002,421,9092,434,9191,656,9421,569,3911,452,6291,277,8411,097,1981,092,481774,162727,6480663,267537,573437,791388,797314,157
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,203,736
2,294,377
2,311,910
2,229,120
2,403,145
2,286,472
2,868,316
2,928,180
3,059,416
2,883,798
2,993,596
3,242,033
3,450,726
3,203,381
3,125,824
2,950,563
2,755,719
2,748,033
2,771,846
2,394,716
2,365,757
2,365,7572,394,7162,771,8462,748,0332,755,7192,950,5633,125,8243,203,3813,450,7263,242,0332,993,5962,883,7983,059,4162,928,1802,868,3162,286,4722,403,1452,229,1202,311,9102,294,3772,203,73600000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
709,689
637,341
608,845
508,112
625,760
410,344
813,017
661,753
645,761
367,456
485,851
473,550
413,977
249,457
261,866
394,544
270,291
259,844
299,491
278,586
175,356
175,356278,586299,491259,844270,291394,544261,866249,457413,977473,550485,851367,456645,761661,753813,017410,344625,760508,112608,845637,341709,68900000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,000
4,000
2,000
0
0
0
0
0
0
0
12,000
826
328
560
0
1,150
4,703
8,403
0
0
008,4034,7031,150056032882612,00000000002,0004,0003,000000000000000000000
       Net Receivables 
119,676
143,855
200,766
260,265
310,371
0
365,957
398,692
403,540
443,470
501,077
588,242
612,370
703,864
790,465
845,041
0
972,592
1,096,365
1,107,011
1,279,625
1,261,022
1,405,694
1,561,261
1,762,616
1,814,949
1,907,290
1,800,646
2,176,825
2,415,503
2,306,845
2,082,457
2,021,476
1,898,023
1,955,954
1,724,045
1,526,000
1,555,375
1,555,3751,526,0001,724,0451,955,9541,898,0232,021,4762,082,4572,306,8452,415,5032,176,8251,800,6461,907,2901,814,9491,762,6161,561,2611,405,6941,261,0221,279,6251,107,0111,096,365972,5920845,041790,465703,864612,370588,242501,077443,470403,540398,692365,9570310,371260,265200,766143,855119,676
       Other Current Assets 
24,187
10,273
18,526
23,577
32,648
0
19,165
68,136
56,412
69,377
89,849
101,269
98,415
99,627
84,389
86,422
0
4,355
9,305
3,378
90,406
112,790
77,629
99,379
101,807
134,519
122,841
159,697
116,045
132,417
134,620
205,633
113,796
111,461
114,099
13,442
6,082
4,911
4,9116,08213,442114,099111,461113,796205,633134,620132,417116,045159,697122,841134,519101,80799,37977,629112,79090,4063,3789,3054,355086,42284,38999,62798,415101,26989,84969,37756,41268,13619,165032,64823,57718,52610,27324,187
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
593,524
733,337
714,103
777,936
805,704
773,011
814,734
978,160
968,755
1,077,350
1,133,751
1,051,541
1,038,716
1,066,688
1,054,505
996,888
982,350
977,313
980,845
947,068
940,429
940,429947,068980,845977,313982,350996,8881,054,5051,066,6881,038,7161,051,5411,133,7511,077,350968,755978,160814,734773,011805,704777,936714,103733,337593,52400000000000000000
       Property Plant Equipment 
53,143
79,949
95,013
100,312
123,385
0
128,146
137,972
161,156
167,402
195,333
197,653
210,901
218,780
222,134
221,017
239,289
231,020
233,403
227,826
246,784
245,421
250,252
243,988
245,391
236,078
261,120
254,636
277,426
264,711
265,611
251,078
233,939
221,055
216,572
214,632
204,237
199,943
199,943204,237214,632216,572221,055233,939251,078265,611264,711277,426254,636261,120236,078245,391243,988250,252245,421246,784227,826233,403231,020239,289221,017222,134218,780210,901197,653195,333167,402161,156137,972128,1460123,385100,31295,01379,94953,143
       Goodwill 
34
34
0
0
0
0
0
0
0
0
48,454
111,089
112,912
128,093
121,782
121,782
0
121,459
153,411
153,411
154,261
154,476
154,261
154,261
154,644
154,644
154,644
154,644
155,022
155,022
154,644
154,644
142,413
142,413
142,414
142,414
115,804
115,804
115,804115,804142,414142,414142,413142,413154,644154,644155,022155,022154,644154,644154,644154,644154,261154,261154,476154,261153,411153,411121,4590121,782121,782128,093112,912111,08948,454000000003434
       Intangible Assets 
8,655
8,419
8,149
7,995
7,752
0
7,634
7,575
7,601
7,535
56,007
118,579
120,338
135,503
130,464
130,368
0
7,123
1,988
8,676
11,328
10,521
10,687
28,545
32,160
31,564
31,139
32,377
31,323
30,778
30,917
30,686
29,817
29,611
34,825
34,969
34,296
34,564
34,56434,29634,96934,82529,61129,81730,68630,91730,77831,32332,37731,13931,56432,16028,54510,68710,52111,3288,6761,9887,1230130,368130,464135,503120,338118,57956,0077,5357,6017,5757,63407,7527,9958,1498,4198,655
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
66,203
30,871
80,586
94,628
76,091
318,748
119,243
115,165
163,918
179,526
142,268
132,269
137,335
126,594
61,710
54,254
54,951
50,083
50,029
52,887
52,88750,02950,08354,95154,25461,710126,594137,335132,269142,268179,526163,918115,165119,243318,74876,09194,62880,58630,87166,203100000000000000000
> Total Liabilities 
60,253
92,296
91,823
131,580
192,968
0
218,914
250,409
233,193
223,671
360,650
494,667
565,618
630,637
772,582
771,140
0
1,136,352
1,320,158
1,289,886
1,386,004
1,594,861
1,430,073
1,919,349
2,103,795
2,207,828
2,178,041
2,324,848
2,550,662
2,724,732
2,533,339
2,455,822
2,450,480
2,246,130
2,212,033
2,244,385
2,027,092
1,989,211
1,989,2112,027,0922,244,3852,212,0332,246,1302,450,4802,455,8222,533,3392,724,7322,550,6622,324,8482,178,0412,207,8282,103,7951,919,3491,430,0731,594,8611,386,0041,289,8861,320,1581,136,3520771,140772,582630,637565,618494,667360,650223,671233,193250,409218,9140192,968131,58091,82392,29660,253
   > Total Current Liabilities 
53,292
66,255
70,315
108,034
182,034
0
210,448
242,755
206,862
199,195
336,923
440,166
532,401
571,092
717,811
745,808
0
1,108,661
1,296,677
1,278,450
1,320,107
1,328,854
1,185,362
1,228,639
1,388,179
1,385,644
1,304,626
1,440,959
1,736,518
1,910,246
1,943,555
1,807,831
1,836,434
1,636,075
1,592,066
1,636,767
1,395,459
1,349,228
1,349,2281,395,4591,636,7671,592,0661,636,0751,836,4341,807,8311,943,5551,910,2461,736,5181,440,9591,304,6261,385,6441,388,1791,228,6391,185,3621,328,8541,320,1071,278,4501,296,6771,108,6610745,808717,811571,092532,401440,166336,923199,195206,862242,755210,4480182,034108,03470,31566,25553,292
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
823,900
881,900
852,900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000852,900881,900823,90000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
823,900
881,900
852,900
809,210
854,500
759,341
761,026
694,749
641,790
555,659
584,806
690,246
607,713
845,150
682,807
778,870
663,252
571,006
633,630
443,695
465,989
465,989443,695633,630571,006663,252778,870682,807845,150607,713690,246584,806555,659641,790694,749761,026759,341854,500809,210852,900881,900823,90000000000000000000
       Accounts payable 
11,362
21,553
14,662
19,182
25,825
0
29,632
25,335
8,460
19,787
24,529
30,194
55,957
52,515
68,261
66,027
0
151,384
216,502
216,452
268,843
293,422
239,476
236,297
440,624
452,264
531,945
604,432
583,758
635,282
717,841
722,420
724,882
731,952
806,641
800,411
747,099
732,592
732,592747,099800,411806,641731,952724,882722,420717,841635,282583,758604,432531,945452,264440,624236,297239,476293,422268,843216,452216,502151,384066,02768,26152,51555,95730,19424,52919,7878,46025,33529,632025,82519,18214,66221,55311,362
       Other Current Liabilities 
28,411
23,751
26,415
27,851
36,011
0
27,463
44,923
50,626
43,225
145,591
161,971
169,820
160,953
125,925
115,894
0
11,245
12,787
9,715
176,665
150,971
149,615
208,896
204,700
266,936
176,179
221,116
298,194
501,028
211,521
375,149
210,584
220,690
160,165
14,088
17,676
14,531
14,53117,67614,088160,165220,690210,584375,149211,521501,028298,194221,116176,179266,936204,700208,896149,615150,971176,6659,71512,78711,2450115,894125,925160,953169,820161,971145,59143,22550,62644,92327,463036,01127,85126,41523,75128,411
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27,691
23,481
11,436
65,897
266,007
244,711
690,710
715,617
822,184
873,416
883,889
814,144
814,486
589,785
647,991
614,046
610,055
619,967
607,617
631,632
639,983
639,983631,632607,617619,967610,055614,046647,991589,785814,486814,144883,889873,416822,184715,617690,710244,711266,00765,89711,43623,48127,69100000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-823,900
-881,900
-852,900
0
0
0
0
0
0
32,886
37,795
47,476
39,199
43,550
48,951
31,743
35,143
31,657
32,876
32,867
31,744
31,74432,86732,87631,65735,14331,74348,95143,55039,19947,47637,79532,886000000-852,900-881,900-823,90000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,137
9,425
0
50,000
230,000
230,000
0
0
0
0
0
0
9,348
0
25,688
14,432
33,817
14,432
13,519
0
20,846
20,846013,51914,43233,81714,43225,68809,348000000230,000230,00050,00009,42514,13700000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,587
39,535
39,596
42,262
46,317
42,815
46,302
63,539
41,330
38,339
38,065
39,701
34,017
39,155
35,698
40,197
31,456
29,809
28,220
0
0
0
00028,22029,80931,45640,19735,69839,15534,01739,70138,06538,33941,33063,53946,30242,81546,31742,26239,59639,53534,5870000000000000000
> Total Stockholder Equity
251,999
293,663
342,727
399,245
460,705
470,299
496,849
510,608
843,614
852,755
876,667
889,879
933,386
946,999
1,566,968
1,549,629
0
1,532,533
1,572,214
1,582,452
1,489,173
1,468,199
1,492,818
1,615,958
1,647,647
1,657,764
1,602,137
1,618,715
1,562,079
1,579,349
1,551,894
1,538,508
1,402,964
1,386,743
1,399,315
1,384,543
1,210,913
1,201,140
1,201,1401,210,9131,384,5431,399,3151,386,7431,402,9641,538,5081,551,8941,579,3491,562,0791,618,7151,602,1371,657,7641,647,6471,615,9581,492,8181,468,1991,489,1731,582,4521,572,2141,532,53301,549,6291,566,968946,999933,386889,879876,667852,755843,614510,608496,849470,299460,705399,245342,727293,663251,999
   Common Stock
36,580
38,200
38,200
38,200
38,200
0
38,200
38,200
50,940
50,940
50,940
50,940
71,316
71,316
205,144
205,144
205,144
205,144
205,144
205,144
205,144
205,144
205,144
205,144
205,027
205,027
205,019
205,019
205,019
205,019
205,019
205,019
203,517
203,517
203,517
0
0
0
000203,517203,517203,517205,019205,019205,019205,019205,019205,019205,027205,027205,144205,144205,144205,144205,144205,144205,144205,144205,144205,14471,31671,31650,94050,94050,94050,94038,20038,200038,20038,20038,20038,20036,580
   Retained Earnings 
82,896
65,825
114,889
171,407
232,867
0
269,010
282,770
301,784
310,925
334,838
348,050
391,557
405,169
432,712
455,355
478,584
472,956
513,023
554,946
594,937
571,213
586,817
617,169
636,631
646,538
639,894
637,489
611,458
632,644
613,138
606,444
457,041
442,133
458,571
406,514
254,251
257,408
257,408254,251406,514458,571442,133457,041606,444613,138632,644611,458637,489639,894646,538636,631617,169586,817571,213594,937554,946513,023472,956478,584455,355432,712405,169391,557348,050334,838310,925301,784282,770269,0100232,867171,407114,88965,82582,896
   Capital Surplus 00000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-39,983000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,668
0
2,460
0
3,209
97,412
99,346
98,617
98,558
121,045
91,718
87,526
78,826
73,023
96,178
95,337
91,164
0
0
0
00091,16495,33796,17873,02378,82687,52691,718121,04598,55898,61799,34697,4123,20902,46008,668000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,006,134
Cost of Revenue-1,613,442
Gross Profit392,692392,692
 
Operating Income (+$)
Gross Profit392,692
Operating Expense-1,993,077
Operating Income13,057-1,600,385
 
Operating Expense (+$)
Research Development43,211
Selling General Administrative211,355
Selling And Marketing Expenses0
Operating Expense1,993,077254,566
 
Net Interest Income (+$)
Interest Income7,512
Interest Expense-76,188
Other Finance Cost-1,165
Net Interest Income-69,841
 
Pretax Income (+$)
Operating Income13,057
Net Interest Income-69,841
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-192,50313,057
EBIT - interestExpense = -76,188
-158,572
-82,384
Interest Expense76,188
Earnings Before Interest and Taxes (EBIT)0-116,315
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-192,503
Tax Provision--35,728
Net Income From Continuing Ops-156,775-156,775
Net Income-158,572
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net069,841
 

Technical Analysis of Thalys
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Thalys. The general trend of Thalys is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Thalys's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wuhan Thalys Med Tech Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.25 < 11.46 < 11.59.

The bearish price targets are: 5.97 > 5.2.

Tweet this
Wuhan Thalys Med Tech Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wuhan Thalys Med Tech Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wuhan Thalys Med Tech Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wuhan Thalys Med Tech Co Ltd. The current macd is 0.00601411.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Thalys price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Thalys. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Thalys price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Wuhan Thalys Med Tech Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWuhan Thalys Med Tech Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wuhan Thalys Med Tech Co Ltd. The current adx is 16.99.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Thalys shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Wuhan Thalys Med Tech Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wuhan Thalys Med Tech Co Ltd. The current sar is 7.23.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Wuhan Thalys Med Tech Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wuhan Thalys Med Tech Co Ltd. The current rsi is 50.08. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Wuhan Thalys Med Tech Co Ltd Daily Relative Strength Index (RSI) ChartWuhan Thalys Med Tech Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wuhan Thalys Med Tech Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Thalys price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Wuhan Thalys Med Tech Co Ltd Daily Stochastic Oscillator ChartWuhan Thalys Med Tech Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wuhan Thalys Med Tech Co Ltd. The current cci is 46.80.

Wuhan Thalys Med Tech Co Ltd Daily Commodity Channel Index (CCI) ChartWuhan Thalys Med Tech Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wuhan Thalys Med Tech Co Ltd. The current cmo is 2.00120336.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Wuhan Thalys Med Tech Co Ltd Daily Chande Momentum Oscillator (CMO) ChartWuhan Thalys Med Tech Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wuhan Thalys Med Tech Co Ltd. The current willr is -51.89873418.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Thalys is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Wuhan Thalys Med Tech Co Ltd Daily Williams %R ChartWuhan Thalys Med Tech Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wuhan Thalys Med Tech Co Ltd.

Wuhan Thalys Med Tech Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wuhan Thalys Med Tech Co Ltd. The current atr is 0.39670865.

Wuhan Thalys Med Tech Co Ltd Daily Average True Range (ATR) ChartWuhan Thalys Med Tech Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wuhan Thalys Med Tech Co Ltd. The current obv is -90,689,282.

Wuhan Thalys Med Tech Co Ltd Daily On-Balance Volume (OBV) ChartWuhan Thalys Med Tech Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wuhan Thalys Med Tech Co Ltd. The current mfi is 62.82.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Wuhan Thalys Med Tech Co Ltd Daily Money Flow Index (MFI) ChartWuhan Thalys Med Tech Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wuhan Thalys Med Tech Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-17STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Wuhan Thalys Med Tech Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wuhan Thalys Med Tech Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.079
Ma 20Greater thanMa 507.146
Ma 50Greater thanMa 1007.672
Ma 100Greater thanMa 2008.594
OpenGreater thanClose7.590
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Thalys with someone you think should read this too:
  • Are you bullish or bearish on Thalys? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Thalys? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wuhan Thalys Med Tech Co Ltd

I send you an email if I find something interesting about Wuhan Thalys Med Tech Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Wuhan Thalys Med Tech Co Ltd.

Receive notifications about Wuhan Thalys Med Tech Co Ltd in your mailbox!